PODDInsulet

Each row is one issuer’s token for Insulet, with the chains it is deployed on. A bold chain is one where these wallets hold a balance. Tokens are not shares: no issuer in the registry publishes a shares-per-token ratio, so a balance is counted one per share and marked where that assumption is doing work.

Tokenized versions of Insulet, the issuer behind each, the chains it is deployed on, and what these wallets hold of it.

Token	Issuer	Chains	You hold
PODDx	xStocks	SOLMNTBNBETHTONINKHYPEARBXLYROP	—

Deployments come from the instrument registry, generated 2026-09-30. A chain listed here is one the issuer has deployed on, not a promise that a market exists on it.

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Type

Common stock

Sector

Healthcare › Medical Devices

Exchange

Nasdaq

Listed since

May 15, 2007

Shares outstanding

69.35M

Employees

5,400

As the market data provider names it. Where that differs from the issuers’ name for the security, both are shown so the difference is visible.